Integra LifeSciences Holdings Corporation (NASDAQ: IART) and Halyard Health (NYSE:HYH) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, valuation, dividends and profitabiliy.

Profitability

This table compares Integra LifeSciences Holdings Corporation and Halyard Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Integra LifeSciences Holdings Corporation 6.27% 16.79% 7.35%
Halyard Health 3.06% 8.29% 4.44%

Volatility & Risk

Integra LifeSciences Holdings Corporation has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Comparatively, Halyard Health has a beta of 1.78, indicating that its share price is 78% more volatile than the S&P 500.

Institutional and Insider Ownership

86.8% of Integra LifeSciences Holdings Corporation shares are owned by institutional investors. Comparatively, 90.3% of Halyard Health shares are owned by institutional investors. 21.5% of Integra LifeSciences Holdings Corporation shares are owned by insiders. Comparatively, 1.3% of Halyard Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Integra LifeSciences Holdings Corporation and Halyard Health’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Integra LifeSciences Holdings Corporation $1.05 billion 3.65 $240.98 million $0.82 59.85
Halyard Health $1.60 billion 1.25 $178.00 million $1.03 41.37

Integra LifeSciences Holdings Corporation has higher revenue, but lower earnings than Halyard Health. Halyard Health is trading at a lower price-to-earnings ratio than Integra LifeSciences Holdings Corporation, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings for Integra LifeSciences Holdings Corporation and Halyard Health, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integra LifeSciences Holdings Corporation 0 2 8 0 2.80
Halyard Health 0 1 3 0 2.75

Integra LifeSciences Holdings Corporation currently has a consensus price target of $52.35, indicating a potential upside of 6.66%. Halyard Health has a consensus price target of $41.67, indicating a potential downside of 2.21%. Given Integra LifeSciences Holdings Corporation’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Integra LifeSciences Holdings Corporation is more favorable than Halyard Health.

Summary

Integra LifeSciences Holdings Corporation beats Halyard Health on 10 of the 14 factors compared between the two stocks.

Integra LifeSciences Holdings Corporation Company Profile

Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement solutions. It sells products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care. It also sells regenerative technology products for treating acute wounds, such as burns, and chronic wounds, including diabetic foot ulcers and surgical tissue repair. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery.

Halyard Health Company Profile

Halyard Health, Inc. is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections. The Company address healthcare needs, such as reducing the use of opioids, while helping patients move from surgery to recovery. The Medical Devices segment’s products include post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems and enteral feeding tubes. The S&IP segment includes product offerings, such as sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves.

Receive News & Ratings for Integra LifeSciences Holdings Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integra LifeSciences Holdings Corporation and related companies with MarketBeat.com's FREE daily email newsletter.